Seres Therapeutics Inc (MCRB) Event Aug. 03, 2022, 00:00 UTC (75% Positive) Seres Therapeutics, Inc. (MCRB) Reports 31% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:41 a.m. 🏢 Seres Therapeutics Inc (MCRB) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-03 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-83.80M $-121.36M $37.56M +30.95% 📉 Total Assets $354.86M $273.20M $81.66M +29.89% 📈 Total Liabilities $223.35M $250.14M $-26.79M -10.71% 📈 Stockholders' Equity $23.06M $-256.00K $23.31M +9107.03% 📈 Operating Income/Loss $-83.47M $-119.08M $35.61M +29.90% 📉 R&D Expense $65.26M $83.58M $-18.33M -21.93% 📈 Revenues $10.98M $2.71M $8.27M +305.35% 📈 Earningspersharebasic $-0.91 $-1.32 $0.41 +31.06% 📈 Earningspersharediluted $-0.91 $-1.32 $0.41 +31.06% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Seres Therapeutics Inc (MCRB) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document